The pharmacological management of anxiety disorders
Open accessAbstract
Progress in Neurology and Psychiatry is running a series of updated articles on the major psychiatric drug groups, produced in association with the College of Mental Health Pharmacy (www.cmhp.org.uk). In this article, Stephen Bleakley and Simon Davies provide an overview of the main types of anxiety disorders, obsessive compulsive disorder and post-traumatic stress disorder. The article focuses on the drug treatment options and supporting evidence base.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Benzodiazepines enhance the neuronal inhibitory action of GABA via allosteric effects at GABA receptors, leading to enhanced anxiolytic or tranquilized states.
“Benzodiazepines, a class of antianxiety medication, enhance the neuronal inhibitory action of GABA via allosteric effects at GABA receptors, leading to enhanced anxiolytic (reduced anxiety) or tranquilized states (Bleakley and Davies, 2014).”
From The Epigenetics of Anxiety Pathophysiology: A DNA Methylation and Histone Modification Focused Review (2023) · cites this paper as Bleakley and Davies, 2014
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Cipriani, A., Furukawa, T. A., Salanti, G., Geddes, J. R., Higgins, J. P., Churchill, R., Watanabe, N., Nakagawa, A., Omori, I. M., McGuire, H., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60046-5 · Cited by 1,654 · see citing works
Pilot study of secondary prevention of posttraumatic stress disorder with propranolol
Pitman, R. K., Sanders, K. M., Zusman, R. M., Healy, A. R., Cheema, F., Lasko, N. B., Cahill, L., & Orr, S. P. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01279-3 · Cited by 964 · see citing works
Baldwin, D. S., Anderson, I. M., Nutt, D. J., Allgulander, C., Bandelow, B., den Boer, J. A., Christmas, D. M., Davies, S., Fineberg, N., Lidbetter, N., et al. (2014) · Journal of Psychopharmacology · doi:10.1177/0269881114525674 · Cited by 676 · see citing works
Self-citationPharmacotherapy for post traumatic stress disorder (PTSD)
Stein, D. J., Ipser, J. C., Seedat, S., Sager, C., & Amos, T. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002795.pub2 · Cited by 519 · see citing works
Immediate treatment with propranolol decreases posttraumatic stress disorder two months after trauma
Vaiva, G., Ducrocq, F., Jezequel, K., Averland, B., Lestavel, P., Brunet, A., & Marmar, C. R. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00412-8 · Cited by 499 · see citing works
Bandelow, B., Sher, L., Bunevicius, R., Hollander, E., Kasper, S., Zohar, J., Möller, H.-J., WFSBP Task Force on Mental Disorders in Primary Care, & WFSBP Task Force on Anxiety Disorders, O. A. P. (2012) · International Journal of Psychiatry in Clinical Practice · doi:10.3109/13651501.2012.667114 · Cited by 428 · see citing works
Cuijpers, P., Sijbrandij, M., Koole, S. L., Andersson, G., Beekman, A. T., & Reynolds, C. F. (2014) · World Psychiatry · doi:10.1002/wps.20089 · Cited by 424 · see citing works
Soomro, G. M., Altman, D. G., Rajagopal, S., & Oakley Browne, M. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001765.pub3 · Cited by 342 · see citing works
Benzodiazepines: Risks and Benefits. A Reconsideration
Baldwin, D. S., Aitchison, K., Bateson, A., Curran, H. V., Davies, S., Leonard, B., Nutt, D. J., Stephens, D. N., & Wilson, S. (2013) · Journal of Psychopharmacology · doi:10.1177/0269881113503509 · Cited by 249 · see citing works
Self-citationPost-Traumatic Stress Disorder (PTSD): What We Have Learned and What We Still Have Not Found Out
Flouri, E. (2005) · Journal of Interpersonal Violence · doi:10.1177/0886260504267549 · Cited by 235 · see citing works
Evidence-based pharmacotherapy of post-traumatic stress disorder (PTSD)
Ipser, J. C., & Stein, D. J. (2012) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145711001209 · Cited by 216 · see citing works
Psychotropic Drug Directory 1993
Montgomery, S. A. (1993) · International Clinical Psychopharmacology · doi:10.1097/00004850-199300820-00011 · Cited by 165 · see citing works
Pharmacotherapy for anxiety disorders in children and adolescents
Ipser, J., Stein, D. J., Hawkridge, S. M., & Hoppe, L. J. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005170.pub2 · Cited by 160 · see citing works
Azapirones for generalized anxiety disorder
Chessick, C. A., Allen, M. H., Thase, M. E., Batista Miralha da Cunha, A. A., Kapczinski, F., Silva de Lima, M., & dos Santos Souza, J. J. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006115 · Cited by 144 · see citing works
Pregabalin abuse and dependence in Germany: results from a database query
Gahr, M., Freudenmann, R. W., Hiemke, C., Kölle, M. A., & Schönfeldt‐Lecuona, C. (2013) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-012-1464-6 · Cited by 135 · see citing works
Pregabalin for the treatment of generalized anxiety disorder: an update
Baldwin, D. S., Ajel, Nowak, Rafiq, & Masdrakis, V. G. (2013) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s36453 · Cited by 125 · see citing works
Posttraumatic Stress Disorder (PTSD)
Rosenberg, S. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-385157-4.01074-5 · Cited by 124 · see citing works
Cuijpers, P. J., Sijbrandij, M., Koole, S. L., Andersson, G., Beekman, A. T. F., & Reynolds, C. F. (2014) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.12.3.347 · Cited by 83 · see citing works
Antidepressants for generalized anxiety disorder.
Flynn, C. A., & Chen, Y. C. C. (2003) · PubMed · Cited by 38 · see citing works
Darcis, T., Ferreri, M., Natens, J., Burtin, B., & Deram, P. (1995) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.470100303 · Cited by 34 · see citing works
Review of choice and use of antidepressants
Bleakley, S. (2009) · Progress in Neurology and Psychiatry · doi:10.1002/pnp.107 · Cited by 9 · see citing works
Self-citationAntipsychotics in the treatment of schizophrenia
Parker, C. (2013) · Progress in Neurology and Psychiatry · doi:10.1002/pnp.280 · Cited by 7 · see citing works
Husted, D. S., Shapira, N. A., & Goodman, W. K. (2005) · Humana Press eBooks · doi:10.1385/1-59259-856-0:171 · Cited by 7 · see citing works
Flagged first, then by citations
Research works printed but not linked: 4
- Baldwin D, Woods R, Lawson R, et al. Efficacy of drug treatments for generalized anxiety disorder: systematic review and meta-analysis. BMJ 2011;342:d1199 (www.bmj.com/content/342/bmj.d1199; accessed July 2014).
- Taylor D, Paton C, Kapur S. The Maudsley Prescribing Guidelines, 11th edn. Chichester: Wiley-Blackwell, 2012.
- Nutt D, Malizia A. New insights into the role of the GABA A -benzo- diazepine receptor in psychiatric disorder. Br J Psychiatry 2001; 179:390-6.
- Bleakley S, Baldwin D. Anxiety Disorders. In: Walker R, Whittlesea C. Clinical Pharmacy and Therapeutics, 5th edition. Oxford: Churchill Livingstone, 2011.
Cited by
Sorted by citations
Li, S. H., & Graham, B. M. (2017) · The Lancet Psychiatry · doi:10.1016/s2215-0366(16)30358-3 · Cited by 579 · see citing works
Persaud, N. S., & Cates, H. M. (2023) · eneuro · doi:10.1523/eneuro.0109-21.2021 · Cited by 41 · see citing works
1,4-Benzodiazepines and New Derivatives: Description, Analysis, and Organic Synthesis
Batlle, E., Lizano, E., Viñas, M., & Pujol, M. D. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.79879 · Cited by 19 · see citing works
Overview and management of anxiety disorders
Hanson, C., & Modiba, W. (2017) · South African Pharmaceutical Journal · Cited by 4 · see citing works
Looy, K. V., & de Velde, S. M. V. (2022) · Archives of Public Health · doi:10.1186/s13690-022-00943-x · Cited by 2 · see citing works
The Pharmacological Management of Stress Reactions
Noel, J. M., & Curtis, J. L. (2012) · Springer eBooks · doi:10.1007/978-1-4614-5538-7_16
Looy, K. V., & de Velde, S. M. V. (2022) · Research Square · doi:10.21203/rs.3.rs-1272615/v1
The Pharmacological Management of Stress Reactions
Noel, J. M., & Curtis, J. L. (2019) · Springer eBooks · doi:10.1007/978-1-4939-9098-6_20
Pharmacological and alternative approaches for the management of anxiety disorders: A review
Singh, L., Saroha, A., & Kabra, A. (2025) · AIP conference proceedings · doi:10.1063/5.0272808
- Authors
- Bleakley, S., & Davies, S. J.
- ORCID
- Davies, Simon JC
- Venue
- Progress in Neurology and Psychiatry
- Publisher
- Wiley
- Published
- 2014-11
- Volume
- 18
- Issue
- 6
- Pages
- 27-32
- ISSN
- 1367-7543 (ISSN-L)
- OpenAlex
- W2169036615
- Cited by
- 10
- References
- 23
- Citations by year
- 2025: 1 · 2022: 4 · 2019: 2 · 2017: 1 · 2016: 1 · 2012: 1
- FWCI
- 0.93
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Progress in Neurology and Psychiatry (publishedVersion)
- Topics
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Health Sciences › Medicine › Pharmacology › Treatment of Major Depression
- Social Sciences › Psychology › Clinical Psychology › Psychological Treatments and Disorders
- Keywords
- anxiety disorders, pharmacological management, anxiolytics, obsessive-compulsive disorder, post-traumatic stress disorder
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
